1. Heckroth, M, Luckett, RT, Moser, C, Parajuli, D, Abell, TL. Nausea and vomiting in 2021: a comprehensive update. J Clin Gastroenterol. 2021;55(4):279–299.
Google Scholar | Crossref | Medline2. Singh, P, Yoon, SS, Kuo, B. Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol. 2016;9(1):98–112.
Google Scholar | SAGE Journals | ISI3. Weibel, S, Schaefer, MS, Raj, D, et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: an abridged cochrane network meta-analysis. Anaesthesia. 2021;76(7):962–973.
Google Scholar | Crossref | Medline4. Gan, TJ, Belani, KG, Bergese, S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131(2):411–448.
Google Scholar | Crossref | Medline5. Hesketh, PJ, Kris, MG, Basch, E, et al. Antiemetics: american society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(28):3240–3261.
Google Scholar | Crossref | Medline6. Barrett, TW, DiPersio, DM, Jenkins, CA, et al. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011;29(3):247–255.
Google Scholar | Crossref | Medline7. Egerton-Warburton, D, Meek, R, Mee, MJ, Braitberg, G. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo. Ann Emerg Med. 2014;64(5):526–532.e521.
Google Scholar | Crossref | Medline8. Hendren, G, Aponte-Feliciano, A, Kovac, A. Safety and efficacy of commonly used antiemetics. Expert Opin Drug Metab Toxicol. 2015;11(11):1753–1767.
Google Scholar | Crossref | Medline9. Athavale, A, Athavale, T, Roberts, DM. Antiemetic drugs: what to prescribe and when. Aust Prescr. 2020;43(2):49–56.
Google Scholar | Crossref | Medline10. Gill, SK, Einarson, A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf. 2007;6(6):685–694.
Google Scholar | Crossref | Medline | ISI11. Makic, MB . Management of nausea, vomiting, and diarrhea during critical illness. AACN Adv Crit Care. 2011;22(3):265–274.
Google Scholar | Crossref | Medline12. Guo, X, Qi, X, Fan, P, et al. Effect of ondansetron on reducing ICU mortality in patients with acute kidney injury. Sci Rep. 2021;11(1):19409.
Google Scholar | Crossref | Medline13. Zaitseva, EN, Dubishchev, AV, Yakovlev, DS, Anisimova, VA. [NEPHROPROTECTIVE PROPERTIES OF 5-HT3 RECEPTOR BLOCKER RU-63 IN EXPERIMENTAL ACUTE RENAL FAILURE UNDER HYPERGRAVITY CONDITIONS]. Eksp Klin Farmakol. 2016;79(3):18–26.
Google Scholar | Medline14. Product Information . Metoclopramide Hydrochloride Inravenous, Intramuscular Injection. Fresnius Kabi; 2016.
Google Scholar15. Product Information . ZOFRAN(R) Intravenous Injection, Ondansetron Hydrochloride Intravenous Injection. GlaxoSmithKline; 2012.
Google Scholar16. Product Information . Prochlorperazine Maleate Oral Tablets, Prochlorperazine Oral Tablets. Jubilant Cadista Pharmaceutical Inc.; 2011.
Google Scholar17. Ronco, C, Bellomo, R, Kellum, JA. Acute kidney injury. Lancet. 2019;394(10212):1949–1964.
Google Scholar | Crossref | Medline18. Al-Jaghbeer, M, Dealmeida, D, Bilderback, A, Ambrosino, R, Kellum, JA. Clinical decision support for In-hospital AKI. J Am Soc Nephrol. 2018;29(2):654–660.
Google Scholar | Crossref | Medline19. Hoste, EA, Bagshaw, SM, Bellomo, R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423.
Google Scholar | Crossref | Medline | ISI20. Silver, SA, Long, J, Zheng, Y, Chertow, GM. Cost of acute kidney injury in hospitalized patients. J Hosp Med. 2017;12(2):70–76.
Google Scholar | Crossref | Medline21. von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gøtzsche, PC, Vandenbroucke, JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 16 2007;4(10):e296.
Google Scholar | Crossref | Medline | ISI22. Levin, A, Stevens, PE, Bilous, RW, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013;3(1):1–150.
Google Scholar23. Jones, AE, Trzeciak, S, Kline, JA. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649–1654.
Google Scholar | Crossref | Medline | ISI24. Knaus, WA, Wagner, DP, Draper, EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619–1636.
Google Scholar | Crossref | Medline | ISI25. Strand, K, Flaatten, H. Severity scoring in the ICU: a review. Acta Anaesthesiol Scand. 2008;52(4):467–478.
Google Scholar | Crossref | Medline | ISI26. Kellum, JA, Lameire, N, Group, KAGW. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Critical care (London, England). 2013;17(1):204–204.
Google Scholar | Crossref | Medline | ISI27. Austin, PC . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107.
Google Scholar | Crossref | Medline | ISI28. Xie, D, Yang, W, Jepson, C, et al. Statistical methods for modeling time-updated exposures in cohort studies of chronic kidney disease. Clin J Am Soc Nephrol. 2017;12(11):1892–1899.
Google Scholar | Crossref | Medline29. Austin, PC, Stuart, EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.
Google Scholar | Crossref | Medline | ISI30. Nishtala, PS, Chyou, TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–473.
Google Scholar | Crossref | Medline31. Amini, M, Saboory, E, Pourheydar, B, Bagheri, M, Naderi, R. Involvement of endocannabinoid system, inflammation and apoptosis in diabetes induced liver injury: role of 5-HT3 receptor antagonist. Int Immunopharmacol. 2020;79(1):106158.
Google Scholar | Crossref | Medline32. Niesler, B, Frank, B, Kapeller, J, Rappold, GA. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene. 2003;310(1):101–111.
Google Scholar | Crossref | Medline33. Haneuse, S, VanderWeele, TJ, Arterburn, D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321(6):602–603.
Google Scholar | Crossref | Medline